Publications by authors named "Gilles Pages"

Claim this Profile
I
IF-CRIB: A 3D-printable device to facilitate immunofluorescence experiments and its application in screening and characterizing cells expressing a degradable form of ERK2.
Elsa Berliocchi, Cercina Onesto, Gilles Pagès, Philippe Lenormand, Roser Buscà

Methods· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment.
Arthur Karaulic, Clémence Fournier, Gilles Pagès

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aqueous humor mediator levels as biomarkers of anti-VEGF response in age-related macular degeneration.
Stéphanie Baillif, Sacha Nahon-Esteve, Tanguy Pace-Loscos, Gilles Pagès, Maeva Dufies

Cytokine· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma.
Manon Teisseire, Umakant Sahu, Julien Parola, Meng-Chen Tsai, Valérie Vial

Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing radiotherapy techniques for Triple-Negative breast cancer treatment.
Saharnaz Sarlak, Gilles Pagès, Frédéric Luciano

Cancer Treat Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness.
Saharnaz Sarlak, Delphine Marotte, Arthur Karaulic, Jessy Sirera, Alessandra Pierantoni

Clin Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation.
Jessy Sirera, Saharnaz Sarlak, Manon Teisseire, Alexandrine Carminati, Victoria J Nicolini, Gilles Pages

J Exp Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELRCXCL-CXCR1/2 Pathway Inhibitor.
Oleksandr Grytsai, Maeva Dufies, Julie Le Du, Olivia Rastoin, Leticia Christina Pires Gonçalves

ACS Med Chem Lett· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, Olivia Rastoin, Rosie Dawaliby

J Exp Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
Manon Teisseire, Sandy Giuliano, Gilles Pagès

Biomedicines· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
Sandy Giuliano, Christopher Montemagno, Marie-Angela Domdom, Manon Teisseire, Patrick Brest

Autophagy· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint inhibitors and anti-angiogenic agents: a winning combination.
Patrick Brest, Baharia Mograbi, Gilles Pagès, Paul Hofman, Gerard Milano

Br J Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2.
Roser Buscà, Cercina Onesto, Mylène Egensperger, Jacques Pouysségur, Gilles Pagès

Nucleic Acids Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma.
Christopher Montemagno, Jérôme Durivault, Cécile Gastaldi, Maeva Dufies, Valérie Vial

Mol Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenesis and Lymphangiogenesis in Medulloblastoma Development.
Manon Penco-Campillo, Gilles Pages, Sonia Martial

Biology (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Phenylspirodrimanes from the Sponge-Associated Fungus MUT 3308.
Marie Dayras, Estelle Sfecci, Elena Bovio, Olivia Rastoin, Maeva Dufies, Gilles Pages

Mar Drugs· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas.
Manon Penco-Campillo, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré

Cells· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma.
Anais Hagege, Esma Saada-Bouzid, Damien Ambrosetti, Olivia Rastoin, Julien Boyer

Cell Rep Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Age-Related Macular Degeneration Therapies.
Marie Fabre, Lou Mateo, Diana Lamaa, Stéphanie Baillif, Gilles Pagès

Molecules· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.
Christopher Montemagno, Frédéric Luciano, Gilles Pagès

Methods Mol Biol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma.
Doria Filipponi, Marina Pagnuzzi-Boncompagni, Gilles Pagès

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
Anais Hagege, Damien Ambrosetti, Julien Boyer, Alexandre Bozec, Jérôme Doyen

Theranostics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma.
Marina Pagnuzzi-Boncompagni, Vincent Picco, Valérie Vial, Victor Planas-Bielsa, Ashaina Vandenberghe

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
Lindsay S Cooley, Justine Rudewicz, Wilfried Souleyreau, Andrea Emanuelli, Arturo Alvarez-Arenas

Mol Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study.
Christopher Montemagno, Benjamin Serrano, Jérôme Durivault, Valérie Nataf, François Mocquot

Biochem Biophys Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis